Cargando…
Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls
BACKGROUND: Liquid biopsies have become an integral part of cancer management as minimally invasive options to detect molecular and genetic changes. However, current options show poor sensitivity in peritoneal carcinomatosis (PC). Novel exosome-based liquid biopsies may provide critical information...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175396/ https://www.ncbi.nlm.nih.gov/pubmed/36864326 http://dx.doi.org/10.1245/s10434-023-13219-7 |